
|Articles|November 1, 2003
Single-dose Equivalency Seen
New York - California researchers have challenged the widespread belief among dermatologists that a "triple-dose" methotrexate regimen - in which three small doses of the potent drug are administered in 12-hour intervals -causes less liver toxicity than one large dose given once weekly.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















